ATE294188T1 - Peptidische inhibitoren der lfa-1/icam-1 interaktion - Google Patents

Peptidische inhibitoren der lfa-1/icam-1 interaktion

Info

Publication number
ATE294188T1
ATE294188T1 AT01942364T AT01942364T ATE294188T1 AT E294188 T1 ATE294188 T1 AT E294188T1 AT 01942364 T AT01942364 T AT 01942364T AT 01942364 T AT01942364 T AT 01942364T AT E294188 T1 ATE294188 T1 AT E294188T1
Authority
AT
Austria
Prior art keywords
icam
interaction
lfa
peptidic inhibitors
peptidic
Prior art date
Application number
AT01942364T
Other languages
English (en)
Inventor
Richard S Larson
Original Assignee
Richard S Larson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/483,550 external-priority patent/US6649592B1/en
Application filed by Richard S Larson filed Critical Richard S Larson
Application granted granted Critical
Publication of ATE294188T1 publication Critical patent/ATE294188T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01942364T 2000-01-14 2001-01-16 Peptidische inhibitoren der lfa-1/icam-1 interaktion ATE294188T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/483,550 US6649592B1 (en) 2000-01-14 2000-01-14 Peptide inhibitors of LFA-1/ICAM-1 interaction
US09/760,599 US6630447B2 (en) 2000-01-14 2001-01-16 Peptide inhibitors of LFA-1/ICAM-1 interaction
PCT/US2001/001382 WO2001051508A1 (en) 2000-01-14 2001-01-16 Peptide inhibitors of lfa-1/icam-1 interaction

Publications (1)

Publication Number Publication Date
ATE294188T1 true ATE294188T1 (de) 2005-05-15

Family

ID=27047693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942364T ATE294188T1 (de) 2000-01-14 2001-01-16 Peptidische inhibitoren der lfa-1/icam-1 interaktion

Country Status (7)

Country Link
US (2) US6630447B2 (de)
EP (1) EP1263778B1 (de)
AT (1) ATE294188T1 (de)
AU (1) AU777721B2 (de)
CA (1) CA2397485A1 (de)
DE (1) DE60110396T2 (de)
WO (1) WO2001051508A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
WO2004032861A2 (en) 2002-10-11 2004-04-22 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
US20050048579A1 (en) * 2003-07-07 2005-03-03 Larson Richard S. Tertiary structures of ICAM-1/LFA-1 modulators
WO2005010024A2 (en) * 2003-07-22 2005-02-03 Science & Technology Corporation @ Unm Potent peptide inhibitors and methods of use
JP5105578B2 (ja) 2003-11-05 2012-12-26 サーコード バイオサイエンス インコーポレイテッド 細胞接着のモジュレーター
TW200616634A (en) 2004-10-01 2006-06-01 Bristol Myers Squibb Co Crystalline forms and process for preparing spiro-hydantoin compounds
US7186727B2 (en) 2004-12-14 2007-03-06 Bristol-Myers Squibb Company Pyridyl-substituted spiro-hydantoin compounds and use thereof
US8168655B2 (en) 2005-05-17 2012-05-01 Sarcode Bioscience Inc. Compositions and methods for treatment of eye disorders
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
CN101443080B (zh) * 2006-03-07 2015-01-14 比奥滕普特公司 肽在控制辐射损伤中的用途
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
MX2010004281A (es) 2007-10-19 2010-09-10 Sarcode Corp Composiciones y metodos para el tratamiento de la retinopatia diabetica.
ES2763703T3 (es) 2008-04-15 2020-05-29 Sarcode Bioscience Inc Antagonistas de LFA-1 tópicos utilizados en el tratamiento localizado de trastornos inmunes
WO2009151646A2 (en) 2008-06-13 2009-12-17 Stc.Unm Non-invasive diagnostic agents and methods of diagnosing infectious disease
WO2020163876A1 (en) * 2019-02-08 2020-08-13 The Regents Of The University Of California Compositions and methods involving layilin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613112D0 (en) * 1996-06-21 1996-08-28 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AU2950201A (en) 2001-07-24
EP1263778A1 (de) 2002-12-11
US6630447B2 (en) 2003-10-07
DE60110396T2 (de) 2006-01-19
AU777721B2 (en) 2004-10-28
EP1263778B1 (de) 2005-04-27
DE60110396D1 (de) 2005-06-02
CA2397485A1 (en) 2001-07-19
US20050065070A1 (en) 2005-03-24
US20010034326A1 (en) 2001-10-25
WO2001051508A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
DE60110396D1 (de) Peptidische inhibitoren der lfa-1/icam-1 interaktion
CY1109216T1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE347366T1 (de) Verwendung von activem vitamin d analoga zur behandlung von prostataerkrangkungen
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
DE60315964D1 (de) Verbesserung der herstellung von endogenen gonadotropin
DE69615561D1 (de) Polyether-blockcopolymer micellare zusammensetzungen zur zielgerichteten verabreichung biologischer stoffe
BG108492A (bg) Използване на въглероден окис за подобряване на резултатите при трансплантация на тъкани и органи и потискане на апоптозата
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
FI920771A0 (fi) Hydroxylamidbaserade kollagenasinhibitorer.
CY1107087T1 (el) Μιμητικα θρομβοποιητινης
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
ATE249238T1 (de) Verwendung von thrombin-derivierten peptiden zur therapie von kardiovaskuläre krankheiten
DE50306682D1 (de) Synergistische kombination von seidenproteinen
ATE385807T1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
DE60238408D1 (de) Antitumorale mittel
ATE454155T1 (de) Verwendung von drospirenon zur behandlung von hypertension
DE59005281D1 (de) Pharmazeutische präparate.
ATE90563T1 (de) Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.
YU40796A (sh) Preparati i postupci za tretiranje obolenja koja izazivaju t ćelije

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties